![christmas red bird bell christmas red bird bell](https://i.ebayimg.com/images/g/K0UAAOSwk4tfm6G6/s-l300.png)
"FDA will be using the totality of the available evidence to authorize the fall bivalent boosters," FDA spokesperson Abigail Capobianco said in a statement emailed to CNN last week. White House COVID-19 Response Coordinator Dr. Ashish Jha said recently the updated boosters should be available to the public early- to mid-September, but it is ultimately up to the FDA as to when the shot will get the greenlight.
![christmas red bird bell christmas red bird bell](https://hative.com/wp-content/uploads/2014/04/perler-beads-patterns/33-christmas-grinch.png)
"We have worked closely with the FDA to ensure that Americans will have access to Moderna's updated, bivalent booster, which, if authorized, may offer higher, broader, and more durable protection against COVID-19 compared to the currently authorized booster," said Stephane Bancel, Chief Executive Officer of Moderna. The data they have submitted to the FDA comes from experiments in mice as well as data from humans using a different booster which was updated to protect against the BA. 1 strain of Omicron.
![christmas red bird bell christmas red bird bell](https://i.pinimg.com/originals/62/56/65/625665a3868ff42623016887305fe381.jpg)
#Christmas red bird bell trial
The company says a Phase 2/3 clinical trial on these boosters is now underway. This updated formulation is a bivalent vaccine that will combine the original vaccine with one that targets Omicron sublineages BA. 4 and BA. 5, and would be administered as a 50 microgram dose. Moderna submitted its application to the U.S. Food and Drug Administration for emergency use authorization of its updated COVID-19 vaccine booster for use in people age 18 and older the company said in a news release on Tuesday.